NagaCorp Ltd. announced the re-designation of Dr. Chen from the position of Chief Executive Officer to Senior Chief Executive Officer of the Group with effect from 5 April 2022. Chen was appointed as an executive director of the Company in April 2003. Chen is the founder, controlling shareholder and a member of the Remuneration Committee, the Nomination Committee and the AML Oversight Committee of the Board.

Chen is also a director of several wholly-owned subsidiaries of the Company, and a director of LIPKCO Group Limited which is a substantial shareholder of the Company.